ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

RAPT RAPT Therapeutics Inc

3.67
0.19 (5.46%)
15 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
RAPT Therapeutics Inc NASDAQ:RAPT NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.19 5.46% 3.67 3.18 23.00 3.50 3.26 3.45 356,905 05:00:05

RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September

30/08/2023 9:05pm

GlobeNewswire Inc.


RAPT Therapeutics (NASDAQ:RAPT)
Historical Stock Chart


From Jun 2023 to Jun 2024

Click Here for more RAPT Therapeutics Charts.

RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, today announced that members of the RAPT management team will participate in the following investor conferences in September:

  • Wells Fargo 2023 Healthcare Conference – Fireside chat on Wednesday, September 6, 2023 at 8:00 a.m. ET
  • H.C. Wainwright 25th Annual Global Investment Conference – Presentation on Monday, September 11, 2023 at 2:00 p.m. ET
  • Stifel 2023 Immunology and Inflammation Virtual Summit – Fireside chat on Tuesday, September 19, 2023 at 3:45 p.m. ET
  • Cantor Global Healthcare Conference – Presentation on Tuesday, September 26, 2023 at 10:35 a.m. ET

To access the available live webcasts or subsequent archived recordings of the discussions and presentations, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.

About RAPT Therapeutics, Inc.RAPT Therapeutics is a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology. Utilizing its proprietary discovery and development engine, the Company is developing highly selective small molecules designed to modulate the critical immune drivers underlying these diseases. RAPT has discovered and advanced two unique drug candidates, RPT193 and FLX475, each targeting C-C motif chemokine receptor 4 (CCR4), for the treatment of inflammation and cancer, respectively. The Company is also pursuing a range of targets that are in the discovery stage of development.

Investor Contact:Sylvia Wheelerswheeler@wheelhouselsa.com

Media Contact:Aljanae Reynoldsareynolds@wheelhouselsa.com

1 Year RAPT Therapeutics Chart

1 Year RAPT Therapeutics Chart

1 Month RAPT Therapeutics Chart

1 Month RAPT Therapeutics Chart